Stockreport

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Radiopharm Theranostics Limited - American Depositary Shares  (RADX) 
PDF Radiopharm Ventures, LLC, is a joint venture created in 2022 between MD Anderson Cancer Center and Radiopharm TheranosticsLeading candidate Betabart, a monoclonal antibo [Read more]